Skip to content

The Gene Screening of Chinese Breast Cancer High Risk People

The Gene Screening of Chinese Breast Cancer High Risk People

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-EOC-15007126
Enrollment
Unknown
Registered
2015-09-24
Start date
2015-09-24
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Third Military Medical University(Southwest Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. patients aged <=35 years; 2. patients <=50 years andwith 1 relative A <=50 years having breast cancer and(or) 1 or more than 1 relatives of any age for epithelial ovarian cancer / fallopian tube cancer / primary peritoneal cancer patients a single body; 3. a patients with 2 primary breast cancers Bandthe first onset age <=50 years old; 4. age is not restricted, while 2 or more than 2 relatives with onset of any close relatives of breast cancer and(or) epithelial ovarian cancer, fallopian tube, primary peritoneal carcinoma cancer; 5. patients were male, or having blood relationship close male relatives with breast cancer; 6. patients with epithelial ovarian cancer, fallopian tube carcinoma, primary peritoneal cancer history. (1) relative: the first, two or three.degree relatives; (2) 2 primary breast cancers, including 2 or more definite different sources of primary breast cancers in the same side of the breast, or bilateral breast cance.

Exclusion criteria

Exclusion criteria: 1. do not agree to participate in this study, or have no informed consent; 2. can not provide blood samples; 3. non primary breast cancer, or bilateral breast cancer for the side of the breast cancer metastasis to the contralateral side; 4. lack of clear diagnosis of breast cancer; 5. patients younger than 18 years old without legal guardian consent.

Design outcomes

Primary

MeasureTime frame
BRCA1;BRCA2;

Countries

China

Contacts

Public ContactJiang Jun
jcbd@medmail.com.cn+86 13508319495

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026